Jefferies

Global Healthcare Innovation

Please refer to Jefferies' important disclosure.


European Biotechnology

Peter Welford reports that the value of innovative therapies will increase as pressure from payers grows to ensure pricing reflects pharma-co-economic benefits and real improvements in patients’ quality of life.


Global Pharmaceuticals

Ian Hilliker discusses immuno-oncology and its outsized market potential in pharmaceuticals.


European Specialty Pharmaceuticals & Healthcare Services

James Vane-Tempest says that biosimilars are expected to drive generics growth into the next decade and to be a focus of innovation for the larger generic companies.


U.S. Healthcare Services

Brian Tanquilut explains how the aging U.S. population will drive a significant increase in demand and costs for healthcare services as the baby boomer population ages.


U.S. Life Science Tools/Diagnostics & Dental

Brandon Couillard describes how a revolution in genomics is just beginning that will continue to drive the convergence of the life sciences & diagnostics industries.


European Medical Devices & Diagnostics

Martin Brunninger explains that manufacturers are broadening portfolios and not necessarily focusing on developing cutting-edge products.


U.S. Medical Supplies & Devices

Raj Denhoy notes that the biggest change in the past decade has been the growing importance of proving the economic value in medical intervention.